Anorexia nervosa: gut imbalance fuels eating disorders

According to a Danish study, the gut microbiota of women suffering from anorexia nervosa is profoundly imbalanced. By acting on the gut-brain axis and the metabolism, this imbalance could contribute to the development and persistence of disorders related to the illness, such as loss of weight and appetite.

The gut microbiota

Anorexia nervosa is an eating disorder that affects 1% of the population, with 95% of cases occurring in women. It is characterized by distortions of body image and obsessions with weight loss, leading to a drastic voluntary restriction of food intake.

This in turn leads to emaciation and health complications that can sometimes result in death. The causes of anorexia nervosa remain poorly understood, and its management is complicated, resulting in remission in less than half of cases. Previous studies involving a small number of patients had already associated a gut microbiota imbalance (dysbiosis) with the disorder. Does gut dysbiosis promote the development of the disease?

Profoundly disturbed gut microbiota in anorexic women

Researchers analyzed stool and blood samples taken from 77 women suffering from anorexia nervosa and 70 healthy women of the same age. They compared gut microbiota composition and blood (sidenote: Metabolites Small molecules produced during cellular or bacterial metabolism. For example, short-chain fatty acids are metabolites produced by intestinal microbiota during fermentation of non-digestible complex carbohydrates (fibers, etc.). Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25.  Lamichhane S, Sen P, Dickens AM, et al An overview of metabolomics data analysis: current tools and future perspectives. Comprehensive analytical chemistry. 2018 ; 82: 387-413 ) between the two groups, and indeed found differences. For example, the gut microbiota of the women suffering from anorexia nervosa contained fewer bacteria from the genus Roseburia, which are considered beneficial to health. In addition, the greater the abundance of bacteria from the genus Clostridium, the more severe the anorexic symptoms, suggesting that these species are involved in the regulation of eating behavior.

1% Anorexia nervosa is an eating disorder that affects 1% of the population

95% with 95% of cases occurring in women

Gut microbiota contributes to eating disorders

The researchers then transplanted fecal samples from women suffering from anorexia nervosa to (sidenote: Germ-free mice mice that have no microbes at all, raised in sterile conditions. )  mice. After three weeks of a 30% reduction in food intake (to mimic the eating behaviors of anorexic patients), the mice given fecal samples from anorexia nervosa patients had lost more weight and took longer to return to normal weight than the “control” mice. A functional analysis of the bacteria present in the mice’s feces then confirmed the role of the gut microbiota in controlling eating behavior.

The results of this study suggest that gut dysbiosis and blood metabolite imbalances in women suffering from anorexia nervosa may contribute to the development of the disease. These compounds may act via the bloodstream and through gut-brain neuronal signaling pathways, affecting the regulation of appetite, emotions, and behavior.

The gut microbiota

Learn more

Recommended by our community

"Never heard of the gut microbiota, this is interesting!!" - Rose Liv (From My health, my microbiota)

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Anorexia nervosa: can gut dysbiosis contribute to eating disorders?

A study published in Nature Microbiology reveals that the gut microbiota and serum metabolome of women with anorexia nervosa display alterations thought to contribute to the disease. The study includes work on murine models that reveals some of the mechanisms behind the interrelationships between dietary restriction and gut dysbiosis.

Anorexia nervosa (AN) affects 1% of the population and about 95% of cases occur in women. The disorder is associated with high morbidity and mortality, and treatment leads to remission in less than half of cases. The causes of AN remain unknown but are thought to include both genetic and environmental factors. By influencing the regulation of appetite, behavior, and emotions via the “gut-brain axis”, the gut microbiota and its metabolites may play a role in the disease. Small-scale studies have already demonstrated dysbiosis of the gut microbiota in patients of the disease.

Profoundly disturbed gut microbiota in women suffering from anorexia

A team from the University of Copenhagen in Denmark used shotgun sequencing of fecal samples and serum metabolome profiling to collect data from 77 female AN patients, then compared the results with data taken from 70 healthy women of the same age. The researchers found that the gut microbiota composition of the women suffering from AN differed from that of the healthy women. In particular, there were reduced levels of the bacterial species Roseburia intestinalis and R. inulinivorans, which are involved in the digestion of plant polysaccharides and are beneficial to health.

In addition, Clostridium species were positively correlated with eating disorders and mental health, suggesting they play a role in the regulation of eating behavior and neuropsychiatric symptoms. Lastly, the gut microbiota of these patients presented higher viral diversity and richness, particularly for Lactococcus phages. 
The serum metabolome of AN patients also showed significant differences from that of healthy women. The researchers observed an increase in several bile acids, including indole-3-propionic acid, a metabolite associated with the secretion of glucagon-like peptide 1, which stimulates satiety and slows gastric emptying. Causal inference analyses by the team suggest that bacterial metabolites mediate some of the effects of gut dysbiosis on eating disorders.

Reduced weight gain and altered energy metabolism in mice

The researchers then took (sidenote: Germ-free mice mice that have no microbes at all, raised in sterile conditions. ) emice on a calorie-restricted diet and gave them a fecal microbiota transplant from either the AN women or the healthy women (control mice). After three weeks of a 30% reduction in food intake (to mimic the eating behaviors of anorexia patients), the mice given fecal samples from the AN women had a greater initial weight loss and slower weight regain than the control mice. Furthermore, there was a higher expression of appetite suppressor genes in the hypothalamus of the AN-transplanted mice and of thermogenesis-related genes in their adipose tissue.

The results of this study suggest that gut dysbiosis and altered serum metabolites in women suffering from AN may contribute to the development and maintenance of the disease.  These compounds may act via the bloodstream or neuronal signaling in the gut-brain axis, affecting appetite regulation, emotions, and behavior.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News General Medicine Psychiatry

Osteoporosis: using bacteria to reduce fractures?

According to a study published in Cell Report, the gut microbiota of mice on a nine-week space trip adapted to limit microgravity-linked early osteoporosis, the phenomenon of bone loss observed in astronauts 1.

The gut microbiota

Cosmic radiation, sleep disturbance, loss of bone density... space travel is no easy ride. If we hope to one day wake up fresh and ready to go the day after our arrival on Mars, we’ll need to understand how space affects our body and how to mitigate these effects. This is the goal of the NASA-led Rodent Research 5 mission, which studies changes in the bone structure of rodents sent to the International Space Station (ISS) for several weeks. The first results are surprising: the digestive microbiota seems to adapt to microgravity, with modifications that limit bone loss.

Bone, a constantly changing tissue

Did you think that the bone, once it has reached its maximum size, does not change? Think again! The bone is constantly being remodeled, even in adulthood. Two types of cells are involved in this phenomenon: osteoclasts, which break down old bone, and osteoblasts, which form new bone. When we are healthy, their respective activities are balanced, and the bone is constantly regenerated. However, at menopause, the lack of estrogen promotes the action of osteoclasts and slows down that of osteoblasts: bone is resorbed more and its architecture becomes fragile. This is osteoporosis 2.

Microbiota influenced by space

Mice that spent nine weeks of their short lives on the ISS (the equivalent of several years for an astronaut) returned to Earth with a more diversified microbiota and whose composition had evolved. Certain bacterial species became more abundant, particularly Lactobacillus murinus and Dorea sp., which seem capable of producing molecules known to promote bone regeneration.

1 in 3 women over age 50 years will experience osteoporotic fractures

1 in 5 men over age 50 years will experience osteoporotic fractures

Indeed, it is a mistake to think that bone becomes a “dead” tissue once growth is complete and adulthood reached. On the contrary, bone tissue is constantly being remodeled through a balanced and continuous process of destruction and rebuilding.  However, this balance can break down in the event of illness such as osteoporosis, or during space travel, since the absence of gravity disrupts the process. However, Lactobacillus murinus and Dorea sp. appear to activate when their mouse host is weightless in space, producing molecules that promote bone regeneration. In fact, some of these compounds are more abundant in the blood of rodents that travel in space.

Implications for both astronauts and osteoporosis

In other words, it is as if the mice’s gut microbiota helps their bodies to compensate for the bone loss associated with microgravity in space. However, despite the appeal of this hypothesis, it needs to be validated before any conclusions can be drawn from it in relation to microbiota and bone health. The implications for treatment may be far-reaching: the identification of probiotic bacteria involved in maintaining bone density might not only help astronauts stay healthier in space, it may also benefit many terrestrial patients suffering from bone diseases such as (sidenote: Osteoporosis Osteoporosis is a "skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture". NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001 Jun;94(6):569-73. ) .

Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds 3.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News

International Microbiota Observatory: first edition

Microbiota: essential to health, but limited global awareness

Photo Observatoire: CP Lay Public - EN

The microbiota is made up of billions of microorganisms (bacteria, viruses, fungi, etc.) that live in symbiosis with our body. We do not only have a gut microbiota, but also a skin microbiota, a mouth and lung microbiota, a urinary and vaginal microbiota, etc. All of them make an essential contribution to our health. But is everyone currently aware of the role of microbiota? Do they know how to look after their microbiota? Are they suffering from health problems that they associate with the microbiota? What role do healthcare professionals presently play in informing patients?

To answer these questions, the Biocodex Microbiota Institute commissioned Ipsos to conduct a major international survey of 6,500 people in 7 countries (France, Spain, Portugal, US, Brazil, Mexico and China), called the International Microbiota Observatory.

This exclusive survey reveals a general lack of understanding of the microbiota’s contribution to health, and underlines the essential role of healthcare professionals in imparting knowledge.

The results were presented on June 27, 2023, on the occasion of World Microbiome Day.

International Microbiota Observatory

Discover the 2023 results
Quote Murielle Escalmel

"This first-of-its-kind Observatory has provided a wealth of information on the knowledge, behaviors and expectations of the world’s populations with regard to human microbiota. We should also mention the key role played by healthcare professionals in raising awareness of the right behaviors for looking after microbiota."

Murielle Escalmel, Director of the Biocodex Microbiota Institute

About the Microbiota Institute 

The Biocodex Microbiota Institute is an international hub of knowledge that aims to foster better health by spreading information about human microbiota. To do so, the Institute addresses both healthcare professionals and the general public to raise awareness about the central role of this little-known organ.

Biocodex Microbiota Institute press contact

Olivier Valcke

Public Relations and Head of Publications 
+33 6 43 61 32 58
o.valcke@biocodex.com

Ipsos press contact

Etienne Mercier

Director of the Opinion and Health Division - Ipsos 
+33 6 23 05 05 17
etienne.mercier@ipsos.com

BMI-23.36
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Press room

1st edition of the International Microbiota Observatory

Microbiota: essential to health, but limited global awareness

Photo Observatoire: CP - EN

The microbiota is made up of billions of microorganisms (bacteria, viruses, fungi, etc.) that live in symbiosis with our body. We do not only have a gut microbiota, but also a skin microbiota, a mouth and lung microbiota, a urinary and vaginal microbiota, etc. All of them make an essential contribution to our health. But is everyone currently aware of the role of microbiota? Do they know how to look after their microbiota? Are they suffering from health problems that they associate with the microbiota? What role do healthcare professionals presently play in informing patients?

To answer these questions, the Biocodex Microbiota Institute commissioned Ipsos to conduct a major international survey of 6,500 people in 7 countries (France, Spain, Portugal, US, Brazil, Mexico and China), called the International Microbiota Observatory.

This exclusive survey reveals a general lack of understanding of the microbiota’s contribution to health, and underlines the essential role of healthcare professionals in imparting knowledge.

The results were presented on June 27, 2023, on the occasion of World Microbiome Day.

International Microbiota Observatory

Discover the 2023 results
Quote Murielle Escalmel

"This first-of-its-kind Observatory has provided a wealth of information on the knowledge, behaviors and expectations of the world’s populations with regard to human microbiota. We should also mention the key role played by healthcare professionals in raising awareness of the right behaviors for looking after microbiota."

Murielle Escalmel, Director of the Biocodex Microbiota Institute

About the Microbiota Institute

The Biocodex Microbiota Institute is an international hub of knowledge that aims to foster better health by spreading information about human microbiota. To do so, the Institute addresses both healthcare professionals and the general public to raise awareness about the central role of this little-known organ.

Biocodex Microbiota Institute press contact

Olivier Valcke

Public Relations and Head of Publications 
+33 6 43 61 32 58
o.valcke@biocodex.com

Ipsos press contact

Etienne Mercier

Director of the Opinion and Health Division - Ipsos 
+33 6 23 05 05 17
etienne.mercier@ipsos.com

BMI-23.36
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Press room

Gut microbiota of centenarians provides wealth of insight

Loss of diversity, reduced presence of beneficial bacteria, increase in potential pathogens... As the years go by, the gut microbiota fades away. However, a study on more than 1,500 Chinese individuals suggests that this is not so for centenarians. 1

13589372-Bacteroides-sp-bacteria-illustration.jpg

Less diversity, fewer beneficial micro-organisms, and more opportunistic pathogens: we know that with advancing age, the gut microbiota changes. But what about centenarians, who have managed to live longer, escaping a raft of chronic diseases and infections? To investigate the relationship between the gut microbiota and longevity, researchers at a Chinese research institute compared the gut microbiota of 1,575 individuals aged between 20 and 117, all living in Guangxi province in China, including 314 young adults (20-44 years), 277 adults (45-65 years), 386 seniors (66-85 years), 301 nonagenarians (90-99 years), and 297 centenarians (100-117 years). The results of this new study on the microbiota’s aging process were published in Nature Aging.

Centenarians with the microbiota of a 20-year-old

The bottom line: species diversity in the gut microbiota declines with age, reaching its lowest level in seniors aged 66-85 years. Surprisingly, however, it increases again in nonagenarians and centenarians, with the latter having the richest flora, on a par with younger individuals. However, the researchers believe that longevity is linked not so much to species diversity as to evenness in the relative abundances of the various species.
Other signs of youthfulness and good health in the microbiota of centenarians are an increased presence of potentially beneficial Bacteroidetes compared to seniors and nonagenarians and a reduced presence of potentially pathogenic bacteria, notably those that cause inflammation.

Prevalence

In 2021, there were 593,000 centenarians worldwide :

  • including 132,000 in Japan (0.11% of population),
  • 90,000 in the USA (0.03%),
  • 29,000 in Thailand (0.04%),
  • 27,000 in France (0.04%),
  • 20,000 in Germany (0.02%),
  • 18,000 in Italy (0.03%)
  • and 14,000 in Spain (0.03%).

In 1950, there were 14,000 centenarians worldwide :

  • in 1960, 20,000 ;
  • in 1970, 27,000 ;
  • in 1980, 49,000 ;
  • in 1990, 102,000 ;
  • in 2000, 169,000 ;
  • and in 2010, 308,000 2

Particularity that grows stronger from age 100

Since these initial results suggest that a specific signature may characterize the gut microbiota of centenarians, the researchers went on to conduct a longitudinal study of gut microbial alterations in 45 of the 297 centenarians, from whom a second stool sample was collected 1.5 years later on average. They found the gut microbiota of the centenarians to be characterized by greater evenness in the relative abundance of species, a decrease in inter-individual variation, and stability of the Bacteroidetes population. The evenness of abundances at the start of the study correlated with the stability of the centenarians’ gut microbiota over the 1.5 years, suggesting that this balance of species may protect the gut flora from disruption and aging.

According to the researchers, centenarians show specific microbiota profiles, including an inter-species balance that is not only high for their age but continues to grow, and a stable abundance of Bacteroidetes. Despite their years, their gut flora remains very similar to that of young adults.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gastroenterology

100 years old and the microbiota of a youngster

A gut microbiota that never ages and whose balance stands the test of time. Is this the secret to centenarians’ longevity, explaining their ability to defy the years and illness? 1

The gut microbiota
Photo: 100 ans et un microbiote de jeune premier !

Some say that growing old is a state of mind. However, a new study by Chinese researchers suggests that the secret to a long and healthy life is to be found in the bellies of those who live to a hundred years or more. To be more precise, the answers can be found in their gut microbiota, i.e. the microbial communities made up of billions of bacteria, viruses, fungi – including yeasts – and parasites that live in the warmth of the digestive system.

Their flora rival that of 20-44-year-olds

There’s no avoiding it: the diversity of our microbiota diminishes with age. However, centenarians are the exception to this rule, since their gut microbiota stays unusually rich for their age. Indeed, it is even richer than that of 44-65-year-olds and 66-85-year-olds. So, while (sidenote: Centenaire  live to the age of 100 or more. ) and  (sidenote: Supercentenaire Supercentenarians live to the age of 110 or more. )  have lived for more than a hundred years, they have the microbiota of young adults.

Another peculiarity of centenarians’ microbiota is the strong presence of bacteria from the phylum (sidenote: Bacteroïdetes Bacteroidetes are one of the gut microbiota’s four major bacterial groups (phyla), together with Actinobacteria, Firmicutes, and Proteobacteria. One of the most common Bacteroidetes in the gut flora is the genus Bacteroides. Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes. 2021 Jan-Dec;13(1):1-20. )  compared to seniors aged 66-85 and nonagenarians. However, these beneficial bacteria are usually only found in people under the age of 40 and from this point tend to diminish in favor of other bacteria not always beneficial to our health. At the same time, the flora of centenarians is relatively low in potentially pathogenic bacteria. More beneficial bacteria, less harmful bacteria: is this the magic potion centenarians use to keep illness at bay? Perhaps. In any case, numerous specific characteristics seem to serve as signatures for their exceptional longevity and healthy aging.

Prevalence

In 2021, there were 593,000 centenarians worldwide :

  • including 132,000 in Japan (0.11% of population),
  • 90,000 in the USA (0.03%),
  • 29,000 in Thailand (0.04%),
  • 27,000 in France (0.04%),
  • 20,000 in Germany (0.02%),
  • 18,000 in Italy (0.03%)
  • and 14,000 in Spain (0.03%).

In the year 2000 there were around 170,000 people aged a hundred and over. This number is expected to exceed 20 million by 2100.2,3

Longevity, a question of balance

One last particularity identified by the researchers was that the gut microbiota of centenarians is very balanced in terms of species distribution, with no single bacterium taking the lion’s share to the detriment of others. Rather than declining over time, this relative uniformity in the abundance of the various bacterial species – already incredible when you’ve seen a hundred years – instead seems to consolidate. It may even ensure the stability over time of centenarians’ gut flora and its continued richness in Bacteroidetes. Could this be the key to a long and healthy life?

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Hay fever: has a nasal dysbiosis been under our nose the whole time?

Are you among the roughly 25% of people whose nose gets blocked, runny, and itchy as the summer, or a cat, approaches? Sensitivity to allergens is not the only factor in allergic rhinitis. A dysbiosis of the nasal microbiota also promotes allergic symptoms. In particular, one study 1 suggests that the bacterium Streptococcus salivarius sticks to the nasal mucosa, causing inflammation in the event of an allergic episode. Want to know more about this bacterium? Bless you!

The ENT microbiota Allergic rhinitis
Photo: « Rhume des foins » : la preuve d’une dysbiose nasale pointe le bout de son nez

The nasal microbiota’s involvement in allergic rhinitis had long been suspected. But what is an allergy? An allergy is a chronic disease caused by an exaggerated reaction of immune system cells to normally harmless foreign substances in our body, such as animal hair, food, or pollen.

Studies have already shown reduced nasal microbiota diversity in those who suffer from allergies, which is linked to antibody production typical of the condition. But which bacterial genera or species are responsible for this nasal dysbiosis? And what role do they play in allergy-related respiratory diseases? Researchers decided to compare in detail the nasal microbiota of 55 people suffering from allergic rhinitis with that of 105 healthy individuals. They were on to the right scent, with enlightening results.

Streptococcus salivarius makes itself at home in the nostrils of allergy sufferers

The researchers were able to confirm reduced microbial diversity in the subjects with allergic rhinitis compared to the healthy controls. The Streptococcus genus made all the difference, particularly the Streptococcus salivarius species, which was highly abundant in the allergic patients. In contrast, Staphylococcus epidermidis, a species considered beneficial to the nasal microbiota, dominated in the healthy subjects. However, S. salivarius is regularly found in the mouth and throat. It is even considered probiotic and therefore good for our health, since it produces antimicrobial substances known as bacteriocins. So, are they present in the noses of allergy sufferers to fight harmful germs? No, because when the researchers put the allergy patients’ S. salivarius into contact with bacteria known to colonize the nose, they found that it secreted only small quantities of bacteriocins.

Sticky and inflammatory... can allergies be relieved by dislodging this bacterium from the nose?

To better understand the role of S. salivarius, the researchers transferred these bacteria from the allergic patients to mice, together with Alternaria alternata, an allergen which causes allergic rhinitis, over three days. The sensitized mice reacted by secreting several inflammatory proteins. What’s more, when S. salivarius from allergy patients and S. epidermidis from healthy subjects were brought into contact with mouse nasal mucosa cells, only S. salivarius stimulated inflammation and a biochemical cascade associated with allergic reactions. The gene for mucin-5AC, a “sticky” substance that protects mucous membranes, was also overexpressed, a sign of respiratory hyperreactivity. Lastly, unlike S. epidermidis, S. salivarius adhered more strongly to mucous cells when exposed to the allergen, unless the mice were genetically modified not to produce this mucin. This adhesion increases contact between the bacterium’s pro-inflammatory substances and inflammation receptors in the nasal mucosa.

In short, S. salivarius contributes specifically and directly to episodes of allergic rhinitis, probably due to its ability to stick to the nasal mucosa in the event of allergic episodes. The researchers suggest that antibacterial therapies targeting S. salivarius may provide relief for the many sufferers of this disease. A solution in sight? New treatments? Probiotics? We can already breathe easier.

The ENT microbiota

Learn more
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

By Pr. Karine Clément
Sorbonne University, Inserm, Unité de recherche nutrition et obésités ; approches systémiques [Nutrition and Obesity Research Unit (systemic approaches)], Paris, France; Nutrition Department, Assistance-Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France

Sweeteners replacing sugar

Sweeteners are considered as a worthy alternative to the excessive use of simple sugars, which are considered to be harmful to cardiometabolic health [1]. Sweeteners can be consumed directly or in processed products [2] In Cell, Suez et al. reported the results of a randomised controlled trial which showed that, paradoxically, some sweeteners may disturb glucose tolerance and that some effects are mediated by changes in the gut microbiota [3].

How do you explain that only two sweeteners have an effect on blood sugar levels (saccharin and sucralose) while the four sweeteners tested had an impact on the composition and functions of the gut microbiota?

The use of sweeteners can be suggested in people with metabolic diseases to help them reduce their calorie intake, lose weight and improve their metabolic risk [4]. However, over time, concerns have emerged due to the fact that sweeteners do not have a neutral effect [5, 6]. In 2014, the authors of this publication had already shown that mice consuming high doses of aspartame, saccharin and sucralose developed glucose intolerance due to disturbances in the gut microbiota [7]. In this new research, they have gone one step further by carrying out a well-conducted clinical study in humans. In 120 healthy participants, the researchers assessed the effects on glucose tolerance of sucralose, saccharin, stevia and aspartame administered for 14 days (5 study arms, 20 participants per group and one control group). Sweeteners were used at levels lower than the recommended daily intake. The ingestion of sucrose and sucralose aggravated glucose tolerance, while aspartame and stevia had a neutral effect. These sweeteners had distinct effects on the composition of the oral and faecal microbiota and on key functions (such as purine and pyrimidine metabolism, glycolysis, and amino-acid metabolism). The most significant effect was observed with sucralose. Microbiota transfer studies (human to mouse) have established the causality of effects. Animals colonised with samples from sweetener-supplemented subjects showed varying degrees of altered glucose tolerance. The chemical composition of sweeteners appears to influence the microbiota; however, the precise mechanism by which they exert these variable effects on the host through changes in the faecal microbiota requires further detailed study. More specifically, sucralose, saccharin and stevia are partially metabolised in the upper digestive tract and only a tiny proportion reaches the colon.

Does this mean you recommend that your patients should not use non-nutritive sweeteners, since they may not be physiologically inert?

In my clinical practice, we do not systematically suggest patients use sweeteners, as there is no evidence that they are an effective weight-loss tool. Although, in patients who are unable to lose their sweet tooth, we prefer suggesting the use of natural sweeteners such as steviol glucoside, which can be used on a short-term and reasonable basis. However, the above discussed results highlight the need for a rigorous assessment of the short- and longterm impact of the available sweeteners on human health before deciding whether or not to recommend their continued use as an aid to reducing metabolic risks.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Expert opinion Gastroenterology